Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Candesartan and renal protection: more than blocking angiotensin type 1 receptor? — Daniela Macconi (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?
Shared by
Giuseppe Remuzzi
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?
Article
2008
en
Authors
DM
Daniela Macconi
Giuseppe Remuzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
Angiotensin-Receptor Blockers for Renal Protection in Type 2 Diabetes
Piero Ruggenenti
,
Manuel Macı́a
,
Giuseppe Remuzzi
Article
2005
Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade
Aneliya Parvanova
,
Carlos Chiurchiu
,
Piero Ruggenenti
,
Giuseppe Remuzzi
Article
2009
Increased angiotensin-receptor blocking is not the first option
Piero Ruggenenti
,
Paolo Cravedi
,
Giuseppe Remuzzi
Article
2015
Early renin‐angiotensin system intervention is more beneficial than late intervention in delaying end‐stage renal disease in patients with type 2 diabetes
Bauke Schievink
,
Tobias F. Kröpelin
,
Skander Mulder
,
H.‐H. Parving
,
Giuseppe Remuzzi
,
Jamie P. Dwyer
,
Pepijn Vemer
,
Dick de Zeeuw
,
Hiddo J.L. Heerspink
Article
2005
Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients
Carlos Chiurchiu
,
Giuseppe Remuzzi
,
Piero Ruggenenti
.webp)
Discussion(0)
No comments yet. Be the first to comment.